Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD45RA-depleted mDLI after Haplo-HSCT
NCT04687982Phase 2Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Nov 2018
- Primary completion
- Jan 2020
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of CD45RA depleted donor lymphocyte infusion in hematological malignancy, sponsored by Humanitas Research Hospital. Started Nov 2018; status: completed.
02
Drugs
CD45RA depleted donor lymphocyte infusion
03
Conditions
hematological malignancy
Beyond the preview
Go deeper on NCT04687982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04687982.